HIGHLIGHTS
- who: Marleen Bouhuys and colleagues from the Department of Pediatric Gastroenterology, Hepatology and Nutrition, University of Groningen, University have published the research: De-Escalation of Anti-Tumor Necrosis Factor Alpha Agents and Reduction in Adverse Effects: A Systematic Review, in the Journal: Biomedicines 2022, 1034 of January/14,/2022
- what: The studies described patients with axial spondyloarthritis (8 studies 780 patients) rheumatoid arthritis (7 studies 1458 patients) psoriasis (3 studies 332 patients) or inflammatory bowel disease (2 studies 136 patients). strategies included interval lengthening (12 studies 1317 patients) dose reduction (6 studies 1130 patients) or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.